Read + Share
Amedeo Smart
Independent Medical Education
Jacobson IM, Bourgeois S, Mathurin P, Thuluvath P, et al. The tolerability of sofosbuvir/velpatasvir for 12 weeks in patients treated in the ASTRAL 1, 2 and 3 studies: A pooled safety analysis. J Viral Hepat 2023;30:448-454.PMID: 36740893
Email
LinkedIn
Facebook
Twitter
Privacy Policy